Inventiva S.A (IVA) - Net Assets

Latest as of June 2025: €-9.35 Million EUR ≈ $-10.93 Million USD

Based on the latest financial reports, Inventiva S.A (IVA) has net assets worth €-9.35 Million EUR (≈ $-10.93 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€178.52 Million ≈ $208.71 Million USD) and total liabilities (€187.87 Million ≈ $219.64 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Inventiva S.A asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€-9.35 Million
% of Total Assets	-5.24%
Annual Growth Rate	N/A
5-Year Change	-195.89%
10-Year Change	-349.35%
Growth Volatility	82.35

Inventiva S.A - Net Assets Trend (2013–2024)

This chart illustrates how Inventiva S.A's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Inventiva S.A for the complete picture of this company's asset base.

Annual Net Assets for Inventiva S.A (2013–2024)

The table below shows the annual net assets of Inventiva S.A from 2013 to 2024. For live valuation and market cap data, see IVA stock market capitalisation.

Year	Net Assets	Change
2024-12-31	€-106.65 Million ≈ $-124.68 Million	-232.95%
2023-12-31	€-32.03 Million ≈ $-37.45 Million	-170.43%
2022-12-31	€45.48 Million ≈ $53.17 Million	-48.83%
2021-12-31	€88.87 Million ≈ $103.89 Million	-20.09%
2020-12-31	€111.21 Million ≈ $130.02 Million	+168.68%
2019-12-31	€41.39 Million ≈ $48.39 Million	-32.80%
2018-12-31	€61.60 Million ≈ $72.01 Million	-3.77%
2017-12-31	€64.01 Million ≈ $74.83 Million	+79.18%
2016-12-31	€35.72 Million ≈ $41.76 Million	-16.48%
2015-12-31	€42.77 Million ≈ $50.00 Million	-16.96%
2014-12-31	€51.51 Million ≈ $60.22 Million	-12.72%
2013-12-31	€59.01 Million ≈ $68.99 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Inventiva S.A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 17707718200.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	€957.00K	%
Other Comprehensive Income	€-172.55 Million	%
Other Components	€249.16 Million	%
Total Equity	€-106.65 Million	100.00%

Inventiva S.A Competitors by Market Cap

The table below lists competitors of Inventiva S.A ranked by their market capitalization.

Company	Market Cap
Hana Microelectronics Public Company Limited BK:HANA	$910.67 Million
Tianjin Tianyao Pharmaceuticals Co Ltd SHG:600488	$910.73 Million
Hangzhou Fortune Gas Cryogenic Group Co. Ltd. A SHG:603173	$910.77 Million
InMode Ltd NASDAQ:INMD	$910.84 Million
Sedlmayr Grund und Immobilien AG F:SPB	$910.52 Million
INVEX Controladora S.A.B. de C.V MX:INVEXA	$910.51 Million
Hangzhou Huning Elevator Parts Co Ltd SHE:300669	$910.26 Million
Horizon Bancorp NASDAQ:HBNC	$910.13 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Inventiva S.A's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from -32,032,000 to -106,646,000, a change of -74,614,000.
Net loss of 184,212,000 reduced equity.
New share issuances of 57,338,000 increased equity.
Other comprehensive income decreased equity by 48,562,000.
Other factors increased equity by 100,822,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	€-184.21 Million	-172.73%
Share Issuances	€57.34 Million	+53.76%
Other Comprehensive Income	€-48.56 Million	-45.54%
Other Changes	€100.82 Million	+94.54%
Total Change	€-	%

Book Value vs Market Value Analysis

This analysis compares Inventiva S.A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2013-12-31	€5.88	€4.31	x
2014-12-31	€5.14	€4.31	x
2015-12-31	€4.26	€4.31	x
2016-12-31	€2.27	€4.31	x
2017-12-31	€4.13	€4.31	x
2018-12-31	€3.00	€4.31	x
2019-12-31	€1.76	€4.31	x
2020-12-31	€3.28	€4.31	x
2021-12-31	€2.27	€4.31	x
2022-12-31	€1.10	€4.31	x
2023-12-31	€-0.71	€4.31	x
2024-12-31	€-1.78	€4.31	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Inventiva S.A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -1251.10%
• Asset Turnover: 0.12x
• Equity Multiplier: 0.00x
Recent ROE (0.00%) is above the historical average (-35.43%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	-12.09%	-232.82%	0.04x	1.48x	€-13.04 Million
2014	-14.55%	-228.26%	0.04x	1.42x	€-12.64 Million
2015	-20.63%	-181.00%	0.08x	1.42x	€-13.10 Million
2016	-19.72%	-74.59%	0.19x	1.37x	€-10.62 Million
2017	-26.92%	-264.22%	0.09x	1.16x	€-23.63 Million
2018	-54.57%	-1051.49%	0.04x	1.30x	€-39.78 Million
2019	-73.01%	-431.85%	0.12x	1.38x	€-34.36 Million
2020	-28.43%	-8500.81%	0.00x	1.25x	€-42.74 Million
2021	-55.85%	-1183.50%	0.03x	1.37x	€-58.52 Million
2022	-119.35%	-445.64%	0.10x	2.55x	€-58.82 Million
2023	0.00%	-631.84%	0.25x	0.00x	€-107.22 Million
2024	0.00%	-1251.10%	0.12x	0.00x	€-173.55 Million

Industry Comparison

This section compares Inventiva S.A's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $54,195,048
Average return on equity (ROE) among peers: -104.02%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Inventiva S.A (IVA)	€-9.35 Million	-12.09%	N/A	$910.54 Million
Abionyx Pharma SA (ABNX)	$7.42 Million	-59.27%	0.81x	$123.48 Million
Abivax SA (ABVX)	$11.78 Million	-260.03%	3.39x	$6.97 Billion
Adocia (ADOC)	$45.85 Million	16.61%	0.53x	$111.73 Million
Aelis Farma SA (AELIS)	$1.20 Million	-263.37%	5.00x	$18.95 Million
Biophytis S.A. (ALBPS)	$6.83 Million	-373.49%	2.98x	$1.03 Million
Cellectis (ALCLS)	$450.27 Million	-17.48%	0.11x	$282.27 Million
Advicenne (ALDVI)	$16.92 Million	-83.89%	0.35x	$21.67 Million
Genoway (ALGEN)	$1.90 Million	0.00%	1.85x	$30.11 Million
Integragen (ALINT)	$2.19 Million	0.70%	3.39x	$1.00 Million
Medesis Pharma SA (ALMDP)	$-2.42 Million	0.00%	0.00x	$1.80 Million

About Inventiva S.A

PA:IVA France Biotechnology

Market Cap

$1.05 Billion

€894.96 Million EUR

Market Cap Rank

#9525 Global

#147 in France

Share Price

€4.31

Change (1 day)

+2.50%

52-Week Range

€2.57 - €5.98

All Time High

€15.56